サクサク読めて、アプリ限定の機能も多数！
トップへ戻る
2024年ランキング
www.who.int
The World Health Organization (WHO) has released a new guideline on non-sugar sweeteners (NSS), which recommends against the use of NSS to control body weight or reduce the risk of noncommunicable diseases (NCDs). The recommendation is based on the findings of a systematic review of the available evidence which suggests that use of NSS does not confer any long-term benefit in reducing body fat in
Home/ News/ item/ Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic The WHO Director-General has the pleasure of transmitting the Report of the fifteenth meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the coronavirus 2019 disease (COVID-19) pandemic, held on Thursday 4 May 2023, from 12:00 to 17:00 CET. Dur
Following its 20-23 March meeting, WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) revised the roadmap for prioritizing the use of COVID-19 vaccines, to reflect the impact of Omicron and high population-level immunity due to infection and vaccination. The roadmap continues SAGE’s prioritization of protecting populations at the greatest risk of death and severe disease from SARS-Co
Home/ News/ item/ WHO updates COVID-19 guidelines on masks, treatments and patient care © WHO Zurab A., a public healthcare specialist, receives a dose of the COVID-19 vaccine at Lashvili Pediatric Clinic. WHO has updated its guidelines on mask wearing in community settings, COVID-19 treatments, and clinical management. This is part of a continuous process of reviewing such materials, working with
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529. The B.1.1.529 variant was first reported
Immunization stress-related response: a manual for program managers and health professionals to prevent, identify and respond to stress-related responses following immunization Overview The term “immunization stress-related responses (ISRR)” covers an entire spectrum of manifestations to a stress response in the context of immunization. Individual responses to stress vary from person to person or
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’s properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or the performance of vaccines, therapeutic medicines, diagnostic tools, or other public health and social measures. In June 2020
With more than 100 vaccines currently in various trial phases and some reaching the pre-approval stage or being authorized for emergency use, accurate science reporting has never been more important. Journalists play a vital role in informing the public on science, specifically vaccine, developments, in an unprecedented period of scientific publishing. The situation is constantly evolving but ther
We know that the disease is caused by the SARS-CoV-2 virus, which spreads between people in several different ways. Current evidence suggests that the virus spreads mainly between people who are in close contact with each other, for example at a conversational distance. The virus can spread from an infected person’s mouth or nose in small liquid particles when they cough, sneeze, speak, sing or br
WHO/N.K. Acquah Isaac Owusu Asiedu labels samples at Noguchi Advanced Research Laboratories, where samples of COVID-19 are tested. WHO is supporting Ghana to increase the country’s COVID-19 testing capacity. The country’s ability to test for COVID-19 has increase significantly and innovative technologies like drone drops of samples are being used. This page is no longer updated. Please see COVID-1
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. The COVID-19 vaccine tracker: Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development;Provides analysis and visualization for several COVID-19 vaccine candidate categories;T
Overview The purpose of this document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. This guidance is intended for health care professionals, public health professionals and health authorities that are developing and implementing policies and standard operating procedures (SOP) on the cleaning and disinfection of environmental surfaces
Overview Doing What Matters in Times of Stress: An Illustrated Guide is a stress management guide for coping with adversity. The guide aims to equip people with practical skills to help cope with stress. A few minutes each day are enough to practice the self-help techniques. The guide can be used alone or with the accompanying audio exercises. Informed by evidence and extensive field testing, the
This scientific brief is outdated. For the latest information on natural immunity from COVID-19, please see: COVID-19 natural immunity - 10 May 2021. WHO has published guidance on adjusting public health and social measures for the next phase of the COVID-19 response.1 Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as
Overview This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care managers and health workers. The Annex provides advice on how to manufacture non-medical masks. It is intended for those making non-medical masks a
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March 2020 Good afternoon everyone. In the past week, we have seen a rapid escalation of cases of COVID-19. More cases and deaths have now been reported in the rest of the world than in China. We have also seen a rapid escalation in social distancing measures, like closing sc
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 Good afternoon. In the past two weeks, the number of cases of COVID-19 outside China has increased 13-fold, and the number of affected countries has tripled. There are now more than 118,000 cases in 114 countries, and 4,291 people have lost their lives. Thousands m
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 9 March 2020 Good afternoon. First, I’d like to start with a brief update on the Ebola epidemic in DRC. It’s now three weeks since the last case was reported, and a week since the last survivor left the treatment centre. We are now in the countdown to the end of the outbreak. We
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 3 March 2020 Good afternoon, and thank you once again for joining us in person and also online. Today is my birthday, and I’ve been given a very good gift from DRC, from my own continent Africa. We have now had two weeks without a single reported case of Ebola, and there are cur
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 2 March 2020 Good afternoon to everyone online and in the room. The number of cases in China continues to decline. Yesterday, China reported 206 cases of COVID-19 to WHO, the lowest since the 22nd of January. Only 8 cases were reported outside Hubei province yesterday. Outside C
Why do the virus and the disease have different names? Viruses, and the diseases they cause, often have different names. For example, HIV is the virus that causes AIDS. People often know the name of a disease, but not the name of the virus that causes it. There are different processes, and purposes, for naming viruses and diseases. Viruses are named based on their genetic structure to facilitate
Hackers and cyber scammers are taking advantage of the coronavirus disease (COVID-19) pandemic by sending fraudulent email and WhatsApp messages that attempt to trick you into clicking on malicious links or opening attachments. These actions can reveal your user name and password, which can be used to steal money or sensitive information. If you are contacted by a person or organization that appea
WHO is bringing the world’s scientists and global health professionals together to accelerate the research and development process, and develop new norms and standards to contain the spread of the coronavirus pandemic and help care for those affected. The R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. The solidarity of all countrie
Masks should be used as part of a comprehensive strategy of measures to suppress transmission and save lives; the use of a mask alone is not sufficient to provide an adequate level of protection against COVID-19. If COVID-19 is spreading in your community, stay safe by taking some simple precautions, such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, clean
COVID-19 is the disease caused by a coronavirus called SARS-CoV-2. WHO first learned of this new virus on 31 December 2019, following a report of a cluster of cases of so-called viral pneumonia in Wuhan, People’s Republic of China. The most common symptoms of COVID-19 are fever chillssore throat.Other symptoms that are less common and may affect some patients include: muscle achessevere fatigue
1 Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak Interim guidance 29 January 2020 WHO/nCov/IPC_Masks/2020.1 Introduction This document provides rapid advice on the use of medical masks in communities, at home and at health care facilities in areas that have reported outbreaks caused by the 2019 nov
次のページ
このページを最初にブックマークしてみませんか？
『World Health Organization (WHO)』の新着エントリーを見る
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic)
-sars-cov-2-variant-of-concern)
-outbreak)
-and-the-virus-that-causes-it)
